This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
HIV Vaccines
joint with The Golden Anniversary of B Cell Discovery
Organizer(s): Giuseppe Pantaleo, Rafick P. Sekaly and Leonidas Stamatatos
Date: March 22 - 27, 2015
Location: Fairmont Banff Springs, Banff, AB, Canada
Sponsored by Merck & Co., Inc. Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation
Summary of Meeting:
As the 30th anniversary of the discovery of HIV has come and gone, HIV remains a catastrophic public health concern, with an estimated global prevalence of 34 million HIV-infected persons. Despite the remarkable advances in the development of several biomedical interventions for the prevention of HIV, the importance of developing an effective HIV vaccine has been recognized by a wide spectrum of the scientific community and civil society. Important milestones for the HIV vaccine field were the demonstration that a vaccine regimen could reduce HIV acquisition and the identification of binding IgG envelope (env) antibodies as potential correlates of protection from HIV acquisition. However, broad neutralizing antibodies (bNAbs) are thought to be the main mechanism of protection of the currently available effective vaccines. This meeting addresses the major scientific gaps in the generation of env bNAbs. Major areas covered by the meeting include: 1) Understanding the development of bNAbs in natural infections and following vaccination; 2) Determining predictors of response to vaccines; 3) Reviewing advances in envelope immunogen design; 4) The therapeutic use of bNAbs; 5) The application of novel technologies to monitor the immune response; and 6) The development of therapeutic strategies aimed to functional HIV cure. The meeting will bring together interdisciplinary groups with outstanding expertise in B- and T-cell biology, structural biology, vaccinology and clinical science. It will therefore provide insight into the attendees how innovative basic observations from the bench side may translate into the clinical development of vaccines and therapeutic interventions.
Global Health Travel Award Deadline: October 21 2014
Scholarship Deadline: November 19 2014
Discounted Abstract Deadline: November 19 2014
Abstract Deadline: December 17 2014
Discounted Registration Deadline: January 20 2015
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
Bill & Melinda Gates FoundationMerck & Co., Inc.
We gratefully acknowledge additional support for this conference from:
Canadian HIV Vaccine Initiative ResearchMabtech Inc.ProSci Inc.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found